US Teens Drive Telehealth Abortion Demand
Analysis based on 7 articles · First reported Mar 25, 2026 · Last updated Apr 06, 2026
The study highlights the growing trend of telehealth medication abortion, particularly among younger demographics, which could impact the healthcare and pharmaceutical industries. Increased legal risks for minors and ongoing regulatory debates around Mifepristone could create uncertainty for related businesses.
A new study published in JAMA Health Forum reveals that teens and young adults in the United States are increasingly obtaining medication abortion pills through telehealth services. The study, which examined requests made to an online telemedicine service operating in all 50 states, found that young people aged 18 to 24 are ordering medication abortion at much higher rates than older adults. This trend has accelerated since the United States===Supreme Court of the United States overturned Roe v. Wade in June 2022, leading to an unexpected increase in abortions nationwide, even in states with bans. The rise of telehealth medication abortion is a key driver, expanding access for tens of thousands. Minors face distinct legal and practical barriers, including parental involvement laws, stigma, and lack of transportation or funds. The study suggests that minors are turning to telehealth at higher rates in states with parental involvement laws. Legal risks, such as prosecution for teenagers ordering pills online, are a concern, with states like United States===Idaho passing 'abortion trafficking' laws. Federal efforts have also targeted the United States===Food and Drug Administration's approval of Mifepristone to restrict access for minors.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard